Navneet Majhail, MD, MS, FASTCT
Deputy Physician-in-Chief of Blood Cancers, Sarah Cannon Transplant and Cellular Therapy Network
Dr. Majhail focuses on the continued development of the Sarah Cannon Transplant and Cellular Therapy Network which provides increased access for patients to cutting-edge cell and transplant therapies in the communities served by Sarah Cannon.
Prior to his time with Sarah Cannon, he served as the director of the Cleveland Clinic’s Blood and Marrow Transplant Program while also serving as the vice chair for the Department of Hematology and Medical Oncology and a Professor of Medicine with the Cleveland Clinic Lerner College of Medicine. He is a past-president of the American Society for Transplantation and Cellular Therapy (ASTCT) and has been recognized as a fellow for his contributions to the field of transplantation and cellular therapy. He is a respected thought leader in health outcomes research and has published extensively on the prevention and management of early and late complications of hematopoietic cell transplantation and health policy issues such as healthcare disparities, quality of care, survivorship and economic issues related to transplantation and cellular therapy.
In addition to his work at Sarah Cannon, Dr. Majhail serves as program medical director for the Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center in Nashville, Tenn.